Artemis Therapeutics, Inc. (ATMS)
|Net Income (ttm)||-136,000|
|Trading Day||June 11|
|Day's Range||2.41 - 2.41|
|52-Week Range||0.04 - 3.75|
There are no news available yet.
Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.
|Stock Exchange |
|Ticker Symbol |
The average 12-month stock price forecast for ATMS is 3.50, which is an increase of 45.29% from the latest price.